4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-040022
Chief Executive Officer acquired 349,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Noiman Silvia Chief Executive Officer | 2018-06-06 | Option exercise | +349,400 | $0.00 | $210 | 490,789 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Noiman Silvia Chief Executive Officer | 2018-06-06 | Option exercise · Stock Option (Right to Buy) | −349,400 | 0 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…